# A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

> **NCT04649489** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Jia Fan** · enrollment: 501 (estimated)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** Atezolizumab & Bevacizumab
- **PROCEDURE:** Surgery followed by atezolizumab and bevacizumab

## Key facts

- **NCT ID:** NCT04649489
- **Lead sponsor:** Jia Fan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-19
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 501 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649489, "A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04649489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*